An inspection by the U.S. Food and Drug Administration found significant sanitation and procedural problems at the East Baltimore plant that ruined 15 million doses of the Johnson & Johnson COVID-19 vaccine. Released Wednesday, the new documents shed light on Emergent BioSolutions’ continued lack of federal authorization to distribute the vaccine it has produced. Inspectors found cleaning and sterilization failures; lack of adherence to protocols; and potential cross-contamination in multiple areas.
FDA report finds significant problems at Baltimore plant that contaminated Johnson & Johnson COVID vaccine
April 22, 2021